Download Free Sample Report

Clinical Trials Outsourcing Market, Global Outlook and Forecast 2023-2030

Clinical Trials Outsourcing Market, Global Outlook and Forecast 2023-2030

  • Published on : 26 October 2023
  • Pages :116
  • Report Code:SMR-7838422

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global Clinical Trials Outsourcing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report aims to provide a comprehensive presentation of the global market for Clinical Trials Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trials Outsourcing. This report contains market size and forecasts of Clinical Trials Outsourcing in global, including the following market information:

Global Clinical Trials Outsourcing Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)


The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Phase I Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Clinical Trials Outsourcing include Charles River Laboratories, IQVIA, ICON PLC, Labcorp Drug Development, Syneos Health, Thermo Fisher Scientific, Wuxi AppTec, Parexel and Advanced Clinical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Clinical Trials Outsourcing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Clinical Trials Outsourcing Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Clinical Trials Outsourcing Market Segment Percentages, by Type, 2022 (%)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Global Clinical Trials Outsourcing Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Clinical Trials Outsourcing Market Segment Percentages, by Application, 2022 (%)

  • Cancer
  • CVDs
  • Infectious Diseases
  • Musculoskeletal Diseases
  • Nervous System Disorders
  • Others

Global Clinical Trials Outsourcing Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Clinical Trials Outsourcing Market Segment Percentages, By Region and Country, 2022 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Clinical Trials Outsourcing revenues in global market, 2018-2023 (estimated), ($ millions)
  • Key companies Clinical Trials Outsourcing revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Charles River Laboratories
  • IQVIA
  • ICON PLC
  • Labcorp Drug Development
  • Syneos Health
  • Thermo Fisher Scientific
  • Wuxi AppTec
  • Parexel
  • Advanced Clinical
  • BioAnalytix
  • Curia Global
  • CMED
  • Cromos Pharma
  • Criterium
  • KCR S.A.
  • Medpace
  • Medelis
  • OCT Group
  • ProTrials Research
  • PROMETRIKA
  • Quality Data Service
  • QPS
  • Sofpromed
  • Veristat
  • Worldwide Clinical Trials

Outline of Major Chapters:

Chapter 1: Introduces the definition of Clinical Trials Outsourcing, market overview.
Chapter 2: Global Clinical Trials Outsourcing market size in revenue.
Chapter 3: Detailed analysis of Clinical Trials Outsourcing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Trials Outsourcing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.